Microbiota Research and Therapeutics
Advancing the therapeutic use of intestinal microbiota
2020 Highly Cited Researchers List
The Microbiome Through the Eyes of Micro Artists
What we do
Develop effective and practical restorative microbiota therapies and
discover novel strategies to nurture and maintain healthy microbiota.
Our program pioneered the use of IMT to restore intestinal health
and created the first stool donor program worldwide.
Intestinal Microbiota Transplants and CDI
IMT success rate
IMT capsules produced
Cost to Patients
We are currently recruiting patients with ulcerative colitis for an intestinal microbiota transplant clinical research study.
The U.S. Department of Veterans Affairs is studying the efficacy of IMT for the prevention of recurrent C. difficile infection (CDI) after treatment of recurrent CDI with standard antimicrobial therapy.
Studying the effects of intestinal microbiota transplant in veterans with cirrhosis.
Intestinal microbiota transplants for children with Pitts Hopkins Syndrome and gastrointestinal disorders.
The University of Minnesota Masonic Cancer Center is recruiting patients for an IMT clinical trial to understand the clinical efficacy of IMT treatment for patients with acute myeloid leukemia and patients receiving allogenic hematopoietic stem cell transplants.
Intestinal microbiota transplant for children with autism spectrum disorder who have gastrointestinal disorders.